- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.05. | Jade Biosciences, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 09.05. | Pre-market Movers: ZK International, Jade Biosciences, Twin Vee Powercats, Corvus Pharmaceuticals, Iovance Biotherapeutics | 738 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green ZK International Group Co., Ltd. (ZKIN) is up over... ► Artikel lesen | |
| JADE BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 05.05. | Stifel initiates Jade Biosciences stock with a Buy, $19 target | 2 | Investing.com | ||
| 02.05. | TD Cowen starts Jade Biosciences coverage with Buy rating | 5 | Investing.com | ||
| 01.05. | Jade Biosciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.04. | RTW Biotech Opportunities' Jade Biosciences merges with Aerovate Therapeutics | 1 | QuotedData | ||
| 30.04. | RTW Biotech Opp. - Jade Biosciences merges with Aerovate Therapeutics | - | RNS | ||
| 25.04. | Aerovate Therapeutics, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 21.04. | Aerovate Therapeutics Stockholders Approve Merger Proposal With Jade Biosciences | 2 | RTTNews | ||
| 21.04. | Aerovate Therapeutics approves reverse split ahead of Jade merger | 1 | Investing.com | ||
| 21.04. | Aerovate Therapeutics genehmigt Aktienzusammenlegung vor Fusion mit Jade | 13 | Investing.com Deutsch | ||
| 21.04. | Aerovate Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.04. | Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals | 178 | PR Newswire | -Aerovate Board of Directors approves 1-for-35 reverse stock split-
WALTHAM, Mass., April 21, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE)... ► Artikel lesen | |
| 09.04. | Aerovate Therapeutics announces $69.6 million special dividend | 2 | Investing.com | ||
| 09.04. | Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences | 128 | PR Newswire | Aggregate cash dividend of $69.6 million, or an estimated $2.40 per share
WALTHAM, Mass., April 9, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (Nasdaq:... ► Artikel lesen | |
| 07.04. | Aerovate Therapeutics signals cash dividend ahead of Jade merger | 1 | Investing.com | ||
| 07.04. | Aerovate Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.04. | Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences | 172 | PR Newswire | Cash dividend expected to be in the range of $67.6 - 69.6 million
WALTHAM, Mass., April 7, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE) ("Aerovate")... ► Artikel lesen | |
| 27.03. | Aerovate Therapeutics, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 24.03. | Aerovate Therapeutics, Inc. - S-4/A, Registration of securities, business combinations | 2 | SEC Filings |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 31,550 | -0,32 % | BB Biotech - Optimistic about biotech's long-term prospects | During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory approvals, lower interest rates, commercial execution... ► Artikel lesen | |
| QIAGEN | 39,750 | +0,48 % | Biotech Report: Evotec und Qiagen starten fest in die Handelswoche | (shareribs.com) Frankfurt / New York 26.05.2025 - Biotech-Aktien zeigen sich zum Wochenauftakt in Deutschland überwiegend fest. An der Wall Street findet aufgrund des Memorial Day kein Handel statt.Der... ► Artikel lesen | |
| NOVAVAX | 6,455 | -0,22 % | Schock-News für Novavax Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| STRYKER | 336,30 | -0,18 % | STRYKER CORP - S-8, Securities to be offered to employees in employee benefit plans | ||
| ILLUMINA | 71,79 | -0,84 % | Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? | ||
| CRISPR THERAPEUTICS | 32,200 | +0,62 % | AKTIONÄR-Depotwert CRISPR Therapeutics: Cathie Wood kauft erneut | Die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics kommt seit Monaten nicht von der Stelle. Das aktuelle Niveau hat nun aber Cathie Wood zum Kauf genutzt. Die für Donnerstag veröffentlichten... ► Artikel lesen | |
| AAP IMPLANTATE | 1,320 | +2,33 % | EQS-AFR: aap Implantate AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: aap Implantate AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
aap Implantate AG: Vorabbekanntmachung... ► Artikel lesen | |
| OCUGEN | 0,740 | +0,16 % | Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST-Modifier Gene Therapy for the Treatment of Stargardt Disease | MALVERN, Pa., May 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,426 | +4,03 % | Sangamo stock holds $10 target from H.C. Wainwright on trial optimism | ||
| INTELLIA THERAPEUTICS | 6,100 | +1,03 % | Cathie Wood's ARK buys Intellia, 10x Genomics, sells Tesla stock | ||
| SCORPIUS | 0,050 | 0,00 % | Scorpius Holdings, Inc.: Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia | Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| EDITAS MEDICINE | 1,546 | +1,74 % | Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit | ||
| DEFENCE THERAPEUTICS | 0,514 | 0,00 % | Defence Therapeutics Inc.: Defence Therapeutics to Attend Bio International Convention in Boston, June 2025 | Montreal, Quebec--(Newsfile Corp. - May 28, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 9,550 | +1,02 % | BioCryst reports efficacy of HAE drug across age groups | ||
| KUROS BIOSCIENCES | 28,160 | +0,21 % | Kuros Biosciences AG: Kuros Biosciences to share latest MagnetOs market impact and strategic priorities at Capital Market Day in Zürich | Kuros Biosciences to share latest MagnetOs market impact and strategic priorities at Capital Markets Day in Zürich
Schlieren (Zürich), Switzerland, May 13, 2025 - Kuros Biosciences ("Kuros"... ► Artikel lesen |
Das Unternehmen JADE BIOSCIENCES INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,84 % bei einem Aktienkurs von 7,250 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu JADE BIOSCIENCES INC finden Sie auf Wallstreet Online.